Chrétien, Yves

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Corpechot, C., Abenavoli, L., Rabahi, N., Chrétien, Y., Andréani, T., Johanet, C., Chazouillères, O., & Poupon, R. (2008) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 646

Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis

Corpechot, C., Chrétien, Y., Chazouillères, O., & Poupon, R. (2010) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 235

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis

Poupon, R. E., Bonnand, A.-M., Chrétien, Y., & Poupon, R. (1999) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 209

Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis

Poupon, R., Chazouilleres, O., Corpechot, C., & Chrétien, Y. (2006) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 170

Quality of life in patients with primary biliary cirrhosis

Poupon, R. E., Chrétien, Y., Chazouillères, O., Poupon, R., & Chwalow, J. (2004) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 144

Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis

Corpechot, C., Poujol‐Robert, A., Wendum, D., Galotte, M., Chrétien, Y., Poupon, R. E., & Poupon, R. (2004) · Liver International

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 48

Fibroscan improves the ability of the new prognostic scoring systems to predict outcomes of PBC

Corpechot, C., Gaouar, F., Lemoinne, S., Kemkang, A., Poupon, R., Chrétien, Y., Housset, C., & Chazouillères, O. (2016) · Journal of Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 4